Carole Faig

Carole Faig

Director/Miembro de la Junta en HENRY SCHEIN, INC. .

Fortuna: 614 555 $ al 31/05/2026

64 años
Commercial Services
Health Technology
Distribution Services

Perfil

Carole T.
Faig
currently works at Henry Schein, Inc., as Independent Director from 2023, QuVa Pharma, Inc., as Director, Affinia Therapeutics, Inc., as Independent Director from 2021, Program for Appropriate Technology in Health, as Director from 2022, and The Scan Group, Inc., as Director from 2025.
Ms. Faig also formerly worked at Cue Health, Inc., as Independent Director from 2021 to 2024 and Ernst & Young LLP, as Partner from 1997 to 2020.
Ms. Faig received her undergraduate degree from Sam Houston State University.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
23/03/2026 8.025 ( 0,01 % ) 614 555 $ 31/05/2026

Cargos activos de Carole Faig

EmpresasCargoInicio
HENRY SCHEIN, INC. Director/Miembro de la Junta 18/12/2023
Director/Miembro de la Junta 01/09/2021
Director/Miembro de la Junta -
Director/Miembro de la Junta 01/12/2022
Director/Miembro de la Junta 01/02/2025

Antiguos cargos conocidos de Carole Faig.

EmpresasCargoFin
CUE HEALTH INC. Director/Miembro de la Junta 24/05/2024
Corporate Officer/Principal 01/01/2020
Ver el detalle de la experiencia de Carole Faig.

Formación de Carole Faig.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

97

Relaciones de 1er grado

8

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas8

Distribution Services

Commercial Services

Consumer Services

Commercial Services

Commercial Services

Health Technology

Health Technology

Health Technology